lobbying_activities: 1330573

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1330573	3e3ffc18-583a-4982-b223-37d701556126	Q4	THE LENKER GROUP LLC	400888599	SHIRE PLC	2012	fourth_quarter	HCR	User fees, drug shortages, DEA quotas, exclusivity periods, orphan drugs, health care reform implementation, drug innovation and patient access, approval pathways, priority vouchers, ESRD PPS, pharmaceutical and biotech related legislation; issues surrounding ADHD, tax reform, drug importation, eating disorders, orphan drug tax credit, annual fees on orphan drugs, FDASIA implementation, drug compounding	HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),SENATE	30000		0	0	2013-01-03T13:19:08.300000-05:00